MedTrace Logo

Analysis of Hemostatic Agents Compared to Physiologic Hemostasis

NCT03068728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2019-04-04

No results posted yet for this study

Summary

This study is a prospective comparison between absorbable hemostatic agents as a group and the body's natural hemostatic ability without aid of therapy in patients undergoing bilateral sinus surgery with or without septoplasty.

Conditions

  • Rhino Sinusitis

Interventions

DEVICE

Arista

DEVICE

Nexfoam

DEVICE

Nasopore

Sponsors & Collaborators

  • University of Kentucky

    collaborator OTHER

  • St. Louis University

    lead OTHER

Principal Investigators

  • Jastin L Antisdel, MD · St. Louis University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-13
Primary Completion
2017-04-10
Completion
2017-04-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03068728 on ClinicalTrials.gov